Article

Effectiveness of COVID-19 Vaccines in the US: Real-World Evidence from the National COVID Cohort Collaborative

2022-12-10

Abstract excerpt

BackgroundThe duration of long-term protection against infection and death afforded by various COVID-19 vaccines during periods dominated by different SARS-CoV-2 variants among the general population and type 2 diabetes patients in the US is unknown.MethodsWe analyzed vaccination status and SARS-CoV-2 infection data from more than 10.4 million participants in the National COVID Cohort Collaborative (N3C) during an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 316530ff-49ef-5c03-ac57-0b276aea2962
DOI: 10.2139/ssrn.4287470

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effectiveness of COVID-19 Vaccines in the US: Real-World Evidence from the National COVID Cohort CollaborativeDOI 10.2139/ssrn.4287470Read

Durability of protection post-primary COVID-19 vaccination in the US: matched case-control studySemantic proximity Read

Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care settingSemantic proximity Read

Expert Review of Global Real-World Vaccine Effectiveness Against SARS-CoV-2Semantic proximity Read

A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccinesSemantic proximity Read

Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults with Underlying Medical Conditions in the United StatesSemantic proximity Read

COVID‐19 Vaccine Efficacy and the Evidence on BoostersSemantic proximity Read

Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 vaccine (mRNA-1273.815) in preventing COVID-19-related hospitalizations and medical encounters among adults in the United States: An interim analysisSemantic proximity Read

Reported Effectiveness of COVID-19 Booster Vaccines: A Systematic Review of Early Literature and Implications for Emerging Vaccination PolicySemantic proximity Read

Effectiveness of the 2023–2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19–related Hospitalizations and Medical Encounters Among Adults in the United StatesSemantic proximity Read

COVID-19 Vaccine Effectiveness and the Evidence on Boosters: A Systematic Review (with Partial Evidence on the Omicron Variant)Semantic proximity Read

Real-World Effectiveness of the mRNA-1273 Vaccine Against COVID-19: Interim Results from a Prospective Observational Cohort StudySemantic proximity Read

Modeling the Anticipated Public Health Benefits of the Next-Generation COVID-19 mRNA-1283 vaccine: An Interim U.S. Population-Level Impact AssessmentSemantic proximity Read